Factors relate to the hypercreatininemia event of patients at the risk of metabolic syndrome in Jetis I public health center

Akrom Akrom, Endang Darmawan, Nuril Maulida

Abstract


Metabolic syndrome (MS) is a risk factor for chronic kidney disease (CKD). Adherence to drug therapy is one of the keys to achieving therapeutic targets in MS. Hyperuricemia (>7mg/dL in men &>5.4mg/dL in women) and hypercreatininemia (>1.3 mg/dL) is a sign of kidney function deficiency. Kidney function deficiency is the result of uncontrolled blood pressure and blood sugar levels in MS patients. The objective of the study was to know the description of the incidence of hypercreatininemia and factors related to the incidence of hypercreatininemia in outpatient  at risk of  MS at Jetis Public health center (PHC) I, Bantul, Yogyakarta. The analytical observational research with cross sectional design was performed on 99 MS outpatient at Jetis I Public Health Center (PHC) who fulfilled the inclusion criteria and approved the participation in the study. Blood urea and creatinine levels were determined by spectrophotometer 5010. Demographic, diagnosis and treatment data were colleccted  from medical record. Patient adherence data were collected by interview. Patient compliance was measured by a medication compliance questionnaire. Demographic and clinical  data are presented descriptively. Bivariate analysis with chisquare was performed to determine the value of the relationship between sex, age, hyperuricemia and adherence to the incidence of hypercreatininemia.  About 30.3% of total of outpatients at risk of MS at Jetis I PHC, Bantul, is non-adherence and 69.7% is adherence to the treatment. As many as 44.4% of respondents have hypercreatininemia and 8.1% of respondents have hyperuricemia. There was a relationship between adherence and female sex with the prevalence of hypercreatininemia with an odds ratio of 3.8, 0.26 and 7.1 respectively. Based on the data of the study concluded that non-adherence, male sex and hyperuricemia are associated with the prevalence of hypercreatininemia in patients at risk of MS in Jetis I PHC.


Keywords


metabolic syndrome (MS); adherence level; hypercreatininemia;cross sectional study; Public health center (PHC).

Full Text:

PDF

References


Alfian, R., Akrom, E.Darmawan, 2014. Giving oral counseling by phrmacist improve quality of life of hypertensive patients in rural private hospital in Bantul District Yogyakarta, Proceeding International Conference on restorative Justice, 4 Januari 2014, Yogyakarta

Anonim. 2015. Profil Puskesmas Jetis 1 Tahun 2015. Puskesmas Jetis 1 Bantul : Yogyakarta.

Anonim. 2005. Pharmaceutical care untuk penyakit diabetes mellitus. Bina Farmasi Komunitas dan Klinik,: Depkes RI, Jakarta

Anonim. 2006. Pharmaceutical care untuk penyakit hipertensi. Bina Farmasi Komunitas dan Klinik,: Depkes RI, Jakarta

Bantas K, Yosef HK, Moelyono B. Perbedaan Gender pada Kejadian Sindrom Metabolik pada Penduduk Perkotaan di Indonesia. Jurnal Kesehatan Masyarakat Nasional Vol. 7, No. 5, Desember 2012

Bernard M. Y. Cheung & Chao Li. 2012. Diabetes and Hypertension: Is There a Common Metabolic Pathway? Curr Atheroscler Rep 14:160–166

Carr, M.C. 2003. The emergene of metabolic syndrome with menopause. The journal of clinical Endocrinology and Metabolism. 2003; 88; 2404-11

Cheung CY, Tso AW, Cheung BM, et al. 2011. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol ;164:381–8.

Codario, ronald a. md, facp. 2011. Type 2 diabetes, pre-diabetes, and the metabolic syndrome, Second Edition Springer Science+Business Media, LLC

Crame J. A. r,1 A´ . Benedict, N. Muszbek, A. Keskinaslan, Z. M. Khan. 2008. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract, January 2008, 62, 1, 76–87

Idris, F.,2014. Pengintegrasian Program Preventif Penyakit Diabetes Melitus Tipe 2 PT Askes (Persero) ke Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan), J Indon Med Assoc, Volum: 64, Nomor: 3, Maret 2014

Hernaningtyas. 2012. Hipertensi, Obesitas sentral, dan Diabetes Mellitus (komponen sindrom metabolik) sebagai predictor kejadian penyakit ginjal kronik : studi kohort retrospektif pada penduduk Kecamatan Blahbatuh Gianyar Bali. Tesis. Program Pascasarjana Universitas Udayana Denpasar: Bali

International Diabetes Federation, 2006, The IDF Concencus Worldwide Definition of the Metabolic Syndrome, (online) (www.idf.org, diakses 05 Mei 2016)

International Diabetes Federation, 2014. Diabetes Atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2014

Kee, J. L.F., 2007, Pedoman Pemeriksaan Laboraturium & Diagnostik. Edisi 6. Jakarta : EGC

Lingga, L., 2012. Program Anti-X Tanpa Obat, Sindrom X: Diabetes Tipe-2, Hiperkolesterolemia, dan Hipertrigliserida, Hipertensi, dan Obesitas. Jakarta: PT Elex Media Komputindo.

Neki, N.S., Gupta, H., MEeena, R., Mani, T., 2015. A Study of Association of Hyperuricemia with Progressive Diabetec Nephropathy, JIMSA Jan. - Mar. 2015 Vol. 28 No. 1

Martínez, Yolanda V, Carlos A Prado-Aguilar, Ramón A Rascón-Pacheco and José J Valdivia-Martíne. 2008. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Services Research; 8:164 doi:10.1186/1472-6963-8-164

Morisky DE, Ang A, Krousel-Wood M, Ward HJ. 2008. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348-354.

Mulyani, R. 2016. Hubungan kepatuhan dengan keberhasilan terapi berbasis kombinasi insulin dan obat antidiabetik oral pada pasien diabetes mellitus tipe 2 diinstalasi rawat jalan rumah sakit umum daerah Ulin Banjarmasin. Prosiding Rakernas dan Pertemuan Ilmiah Tahunan Ikatan Apoteker Indonesia 2016, e-ISSN : 2541-0474

Olenak, J.L., Calpin M., 2010. Establishing a cardiovascular health and wellness program in a community pharmacy: screening for metabolic syndrome. J Am Pharm Assoc. 2010;50(1):32-36

Puspita, E. 2016. Faktor-faktor yang berhubungan dengan kepatuhan penderita hipertensi dalam menjalani pengobatan. Skripsi. Fakultas Ilmu keolahragaan, Jurusan Ilmu Kesehatan Masyarakat. Universitas Negeri Semarang. Semarang : Indonesia.

Putri, R.I., 2015. Faktor Determinan Nefropati Diabetik pada penderita Diabetes Mellitus di RSUD Dr. M. Soewandhie Surabaya. Jurnal Berkala Epidiomologi, Vol. 3 No. 1 Januari 2015 : 109-121

Rahma, A., Arso, S.P., Suparwati, A., 2015. Implementasi Fungsi Pokok Pelayanan Primer Puskesmas sebagai Gatekeeper dalam Program JKN (studi di Puskesmas Juwana Kabupaten Pati), JURNAL KESEHATAN MASYARAKAT (e-Journal) Volume 3, Nomor 3, April 2015 (ISSN: 2356-3346)

Ramadhan, M.R., 2014. Pengaruh ketepatan terapi dan kepatuhan terhadap hasil terapi hipertensi di poliklinik penyakit dalam RSUP Dr. Sardjito Yogyakarta. J. Trop. Pharm. Chem. 2014 Vol 2 No. 5. P-ISSN : 2087-7099; e-ISSN : 2407-6090

Siregar, C. (2006). Farmasi klinik teori dan penerapan. Jakarta : EGC

Sudjatmiko, A., 2011. Faktor-faktor yang berhubungan dengan kemunculan komplikasi kronik pada Penderita Diabetes Mellitus Tipe 2 RSUD Kabupaten Kududs. Skripsi. Semarang ; Fakultas Kesehatan Masyarakat Universitas Diponegoro

Touchette, D., 2010. Improving adherence in the community and clinic pharmacy settings: an emerging opportunity. Pharmacotherapy. 2010;30:425-427.

Verdiansah. Pemeriksaan Fungsi Ginjal. CDK,237,vol.43 no.2 th. 2016

WHO. 2003. Adherence to Long-Term Therapies (Evidence for action). WHO Library Cataloguing-In-Publication Data

Wijaya, I. , Faturrohmah, A., Agustin, W.W., Soesanto, T.G., Kartika, D., 2015. Profil kepatuhan pasien diabetes mellitus Puskesmas Wilayah Surabaya Timur dalam menggunakan obat dengan metode pill count. Jurnal Farmasi Komunitas Vol. 2, No.1 (2015) 18-22




DOI: http://dx.doi.org/10.12928/pharmaciana.v7i2.6717

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Pharmaciana

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Pharmaciana indexed by:

Google ScholarDirectory of Open Access JournalIndonesian Scientific Journal Database (ISJD)Indonesian Publication Index (IPI)CrossrefBielefeld Academic Search Engine (BASE)Sherpa RomeoOpen Academic Journal Index (OAJI)

 

 

 

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.